STATE OF MINNESOTA FIRST MEETING
HOUSE OF REPRESENTATIVES EIGHTY-FIFTH SESSION
BIOSCIENCES AND EMERGING TECHNOLOGIES COMMITTEE & BUSINESS, INDUSTRY AND JOBS COMMITTEE
Representative Tim Mahoney, Chair of the Committee, called the meeting to order at 2:50 PM on December 6, 2007, at Saint Paul RiverCentre, 175 West Kellog Blvd, St. Paul, MN.
The Committee Legislative Assistant noted the roll.
Bioscience and Emerging Technologies Members Present:
MAHONEY, Tim (Chair)
NORTON, Kim (Vice Chair)
Bioscience and Emerging Technologies Members Excused:
Business, Industry and Jobs Members Present:
SALTZMAN, Kathy (Vice Chair)
BAKK, Thomas M.
Business, Industry and Jobs Members Excused:
METZEN, James P. (Chair)
BONOFF, Terri E.
KOCH, Amy T.
NEUVILLE, Thomas M.
ROSEN, Julie A.
TOMASSONI, David J.
A quorum was present.
Introductions and welcome by committee members.
Don Gerhardt, CEO of LifeScience Alley, and Dale Wahlstrom, CEO of BioBusiness Alliance of Minnesota, provided an industry overview. Questions and discussion followed.
Jay Schrankler, Executive Director of the Office for Technology Commercialization at the University of Minnesota, presented commercialization opportunities and challenges.
Curt Kinghorn, CEO of Sirius Strategic and Anoka Medical, discussed early stage funding challenges and investment tax credits.
Dan Baker, NVE Corp, discussed the SBIR Program. Questions followed.
Mark Ungs, ACTx, discussed spin out technologies.
Brent Eilefson, Upsher-Smith Laboratories, discussed the general business climate. Questions and discussion followed.
The meeting was adjourned at 4:21 PM.
Rep. Tim Mahoney, Chair
Committee Legislative Assistant